Daniel Arias
Stock Analyst at Stifel Nicolaus
(4.00)
# 1,728
Out of 4,509 analysts
492
Total ratings
47.8%
Success rate
6%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Maintained: Hold | $36 | $41.44 | -13.13% | 19 | Jun 16, 2026 | |
| ALMR Alamar Biosciences | Maintained: Buy | $28 | $27.40 | +2.19% | 2 | Jun 9, 2026 | |
| TEM Tempus AI | Maintained: Hold | $60 | $55.93 | +7.28% | 11 | Jun 1, 2026 | |
| A Agilent Technologies | Maintained: Buy | $170 | $134.04 | +26.83% | 26 | May 28, 2026 | |
| GH Guardant Health | Maintained: Buy | $130 | $158.40 | -17.93% | 17 | May 28, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $600 | $528.51 | +13.53% | 31 | May 21, 2026 | |
| MTD Mettler-Toledo International | Rated: Buy | $1,600 → $1,400 | $1,299.53 | +7.73% | 29 | May 18, 2026 | |
| WAT Waters | Maintained: Hold | $380 | $373.22 | +1.82% | 28 | May 18, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 | $2.01 | +298.01% | 6 | May 14, 2026 | |
| MXCT MaxCyte | Maintained: Buy | $4 | $1.38 | +189.86% | 15 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $6.36 | -5.66% | 24 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $58.97 | -23.69% | 23 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $50 | $71.36 | -29.93% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 → $10 | $7.95 | +25.79% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $145 | $123.25 | +17.65% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 → $100 | $111.11 | -10.00% | 28 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $207 | $144.88 | +42.88% | 31 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 | $190.05 | -18.44% | 47 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $8 | $10.56 | -24.24% | 18 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 | $200.16 | +29.90% | 26 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $25 | $41.77 | -40.15% | 24 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.25 | +122.22% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $10.21 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.07 | n/a | 13 | Mar 1, 2024 |
Qiagen
Jun 16, 2026
Maintained: Hold
Price Target: $36
Current: $41.44
Upside: -13.13%
Alamar Biosciences
Jun 9, 2026
Maintained: Buy
Price Target: $28
Current: $27.40
Upside: +2.19%
Tempus AI
Jun 1, 2026
Maintained: Hold
Price Target: $60
Current: $55.93
Upside: +7.28%
Agilent Technologies
May 28, 2026
Maintained: Buy
Price Target: $170
Current: $134.04
Upside: +26.83%
Guardant Health
May 28, 2026
Maintained: Buy
Price Target: $130
Current: $158.40
Upside: -17.93%
Thermo Fisher Scientific
May 21, 2026
Maintained: Buy
Price Target: $600
Current: $528.51
Upside: +13.53%
Mettler-Toledo International
May 18, 2026
Rated: Buy
Price Target: $1,600 → $1,400
Current: $1,299.53
Upside: +7.73%
Waters
May 18, 2026
Maintained: Hold
Price Target: $380
Current: $373.22
Upside: +1.82%
Rapid Micro Biosystems
May 14, 2026
Maintained: Buy
Price Target: $8
Current: $2.01
Upside: +298.01%
MaxCyte
May 13, 2026
Maintained: Buy
Price Target: $4
Current: $1.38
Upside: +189.86%
May 11, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $6.36
Upside: -5.66%
May 8, 2026
Rated: Hold
Price Target: $40 → $45
Current: $58.97
Upside: -23.69%
May 7, 2026
Maintained: Hold
Price Target: $65 → $50
Current: $71.36
Upside: -29.93%
May 7, 2026
Rated: Buy
Price Target: $8 → $10
Current: $7.95
Upside: +25.79%
May 7, 2026
Rated: Buy
Price Target: $145
Current: $123.25
Upside: +17.65%
May 6, 2026
Rated: Hold
Price Target: $110 → $100
Current: $111.11
Upside: -10.00%
May 6, 2026
Maintained: Buy
Price Target: $207
Current: $144.88
Upside: +42.88%
May 1, 2026
Maintained: Buy
Price Target: $155
Current: $190.05
Upside: -18.44%
Apr 30, 2026
Maintained: Hold
Price Target: $10 → $8
Current: $10.56
Upside: -24.24%
Apr 22, 2026
Maintained: Buy
Price Target: $260
Current: $200.16
Upside: +29.90%
Mar 2, 2026
Maintained: Buy
Price Target: $20 → $25
Current: $41.77
Upside: -40.15%
Nov 10, 2025
Maintained: Buy
Price Target: $5
Current: $2.25
Upside: +122.22%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $10.21
Upside: n/a
Mar 1, 2024
Maintained: Buy
Price Target: $5
Current: $2.07
Upside: n/a